Compare
Bio Green Med Solution, Inc. vs Greenlane Holdings, Inc. vs Core & Main, Inc.
| Latest fiscal year | Bio Green Med Solution, Inc. BGMS | Greenlane Holdings, Inc. GNLN | Core & Main, Inc. CNM |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-02-01 |
| Revenue | $747.0K | $4.36M | $7.65B |
| Revenue growth (YoY) | n/m | -67.2% | +2.8% |
| Gross margin | n/a | -286.2% | 26.9% |
| Operating margin | n/m | n/m | 9.4% |
| Net margin | -401.3% | n/m | 5.8% |
| Net income | -$3.00M | -$85.58M | $441.00M |
| EPS (Diluted) | -$6.45 | -$11.42 | $2.31 |
| Operating cash flow | -$4.77M | -$16.26M | $650.00M |
| Free cash flow | n/a | -$16.36M | $604.00M |
| Cash & equivalents | $3.50M | $32.51M | $220.00M |
| Total assets | $8.19M | $74.93M | $6.08B |
| Total liabilities | $1.34M | $7.21M | $4.01B |
| Shareholders' equity | $6.84M | $67.87M | $2.00B |
| Return on year-end equity | -43.8% | -126.1% | 22.1% |
| Shares outstanding | 5.40M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Bio Green Med Solution, Inc. | Greenlane Holdings, Inc. | Core & Main, Inc. |
|---|---|---|---|
| Latest | $747.0K Ended 2025-12-31 | $4.36M Ended 2025-12-31 | $7.65B Ended 2026-02-01 |
| 1 year earlier | $43.0K Ended 2024-12-31 | $13.28M Ended 2024-12-31 | $7.44B Ended 2025-02-02 |
| 2 years earlier | $420.0K Ended 2023-12-31 | $65.37M Ended 2023-12-31 | $6.70B Ended 2024-01-28 |
| 3 years earlier | $0 Ended 2022-12-31 | $137.09M Ended 2022-12-31 | $6.65B Ended 2023-01-29 |
| 4 years earlier | $0 Ended 2021-12-31 | $166.06M Ended 2021-12-31 | $5.00B Ended 2022-01-30 |